Viewing Study NCT06423677



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06423677
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2024-05-16

Brief Title: Analgesic Efficacy of Serratus Posterior Superior Intercostal Plane SPSIP Block in Shoulder Arthroscopies
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Organization: Kanuni Sultan Suleyman Training and Research Hospital

Study Overview

Official Title: Evaluation of the Analgesic Efficacy of Serratus Posterior Superior Intercostal Plane SPSIP Block in Shoulder Arthroscopies A Randomized Controlled Prospective Multicenter Study
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients in the block group will be placed in a lateral position with the operated shoulder on top before awakening from surgery After ensuring aseptic conditions the block site will be wiped three times with 10 povidone-iodine the linear ultrasound probe will be covered in a sterile manner While performing the block the Hitachi brand linear ultrasound probe will be placed parallel to the scapular spine on the surgical side and will be slid medially After imaging the 2nd and 3rd ribs on the medial side of the scapular spine the block needle will be advanced under ultrasound guidance onto the 3rd rib After contacting the rib with the needle it will be retracted by 1mm and the block site will be confirmed by injecting sterile 09 NaCl Subsequently patients will be administered 30ml of 025 bupivacaine in a controlled manner

Before awakening both the block group and the non-block group will be administered 1g of paracetamol and 1mgkg of tramadol intravenously In the postoperative period these patients will be provided with multimodal analgesia including intravenous patient-controlled analgesia PCA with 4mgml Tramadol HCl in 100ml NaCl There will be no basal infusion with bolus doses of 20mg and a lockout period of 20 minutes and a total dose limitation of 200mg over 4 hours Patients will be visited at 0 1 6 12 and 24 hours and they will be asked to draw their visual analog scale VAS score on a paper scale The amount of opioid used in the PCA and the need for rescue analgesia Arveles 50mg intravenously will be assessed Patients will routinely receive 4x1g paracetamol in the postoperative period
Detailed Description: Patient Positioning and Preparation

Patient Positioning

Patients in the block group will be placed in a lateral position with the operated shoulder on top before awakening from surgery This positioning facilitates access to the block site and ensures patient comfort

Aseptic Technique

The block site will be prepared by wiping it three times with 10 povidone-iodine to ensure asepsis

The linear ultrasound probe will be covered in a sterile manner to prevent contamination during the procedure

Ultrasound-Guided Block Procedure

Probe Placement and Rib Identification

The Hitachi brand linear ultrasound probe will be placed parallel to the scapular spine on the surgical side

The probe will be slid medially to identify the 2nd and 3rd ribs on the medial side of the scapular spine Accurate identification of these ribs is crucial for proper needle placement

Needle Insertion and Block Site Confirmation

A block needle will be advanced under ultrasound guidance onto the 3rd rib The ultrasound guidance ensures precise needle placement minimizing the risk of complications

Once the needle contacts the rib it will be retracted by 1mm This slight retraction helps position the needle tip correctly for optimal drug delivery

The block site will be confirmed by injecting sterile 09 NaCl The spread of saline under ultrasound visualization confirms the correct location

Anesthetic Administration

Following confirmation of the block site 30ml of 025 bupivacaine will be administered in a controlled manner The controlled administration ensures a steady and effective distribution of the anesthetic agent

Perioperative Analgesia Management

Pre-Awakening Medication

Before awakening from surgery both the block group and the non-block group will receive

1g of paracetamol intravenously

1mgkg of tramadol intravenously

Postoperative Analgesia

Postoperative analgesia will be managed using a multimodal approach including

Intravenous patient-controlled analgesia PCA with 4mgml Tramadol HCl in 100ml NaCl

The PCA will be set with no basal infusion allowing patients to self-administer bolus doses of 20mg with a lockout period of 20 minutes

The total dose limitation will be set at 200mg over 4 hours to prevent overdose and manage pain effectively

Postoperative Assessment and Follow-Up

VAS Score Monitoring

Patients will be visited at the following time intervals postoperatively 0 1 6 12 and 24 hours

During each visit patients will be asked to record their pain levels using the visual analog scale VAS on a paper scale This subjective measure provides valuable insight into the patients pain experience

Opioid Consumption and Rescue Analgesia

The amount of opioid used via PCA will be recorded to evaluate opioid consumption

The need for rescue analgesia will be assessed and documented If required patients will receive 50mg of Arveles intravenously

Routine Postoperative Medication

All patients will receive routine postoperative medication including 4x1g paracetamol to maintain baseline analgesia and reduce overall opioid requirements

Randomization Process

Randomization Protocol

Patients scheduled for surgery will be randomly assigned to either the block group or the non-block group to ensure unbiased allocation and comparability between groups

Randomization will be performed using a computer-generated random number sequence ensuring that each patient has an equal chance of being allocated to either group

Allocation concealment will be maintained by using opaque sealed envelopes containing the group assignments These envelopes will only be opened after patient consent and immediately before the block procedure

Blinding

The study will implement a single-blind design where the patients will be unaware of their group assignment to minimize bias in self-reported outcomes

The healthcare providers responsible for postoperative care and outcome assessment will also be blinded to the group allocation to ensure objective evaluation of the study endpoints

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None